Get started
Author

Kimberly Donnowitz

Observed name: Donnowitz K
Observed institution: Astellas Pharma (United States)
OpenAlex ID: A5116310648
Clinical characteristics and treatment patterns of patients with muscle invasive bladder cancer: A real-world cohort study.
2025 · John L. Gore, Vanessa Shih, et al. · Journal of Clinical Oncology · 2
PDF
Characteristics and Treatment Patterns of Patients with Muscle-Invasive Bladder Cancer in the United States: A Real-World Cohort Study
2026 · John L Gore, Allison Thompson, et al. · Pragmatic and Observational Research
Characteristics and Treatment Patterns of Patients with Muscle-Invasive Bladder Cancer in the United States: A Real-World Cohort Study
2026 · Gore JL, Thompson A, et al. · DOAJ (DOAJ: Directory of Open Access Journals)
Treatment patterns among Medicare beneficiaries with muscle-invasive bladder cancer (MIBC) undergoing radical cystectomy (RC) during 2020-2024.
2026 · Ronald C. Chen, Kimberly Donnowitz, et al. · JCO Oncology Practice
PDF
Treatment patterns among US patients with muscle-invasive bladder cancer (MIBC) undergoing radical cystectomy (RC) during 2021–2024: Retrospective cohort study using the IQVIA database.
2026 · Ronald C. Chen, Kimberly Donnowitz, et al. · JCO Oncology Practice
PDF
Description and management strategies of prespecified treatment emergent adverse events (TEAEs) amongst patients (pts) treated with 1L enfortumab vedotin (EV) + pembrolizumab (P) for la/mUC in a real-world setting.
2026 · David Michael Gill, Lisa Mucha, et al. · Journal of Clinical Oncology
Works count: 6
Citation count: 2
H-index: 1
I10-index:
Year
Topic
Type